---
title: "Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Incidence"
description: "Formulary evidence on Adrabetadex (Lembaz, VTS-270) in Infantile-onset Niemann-Pick disease type C: Incidence. Topics: Guideline incidence estimate and range across national studies, Incidence predicted from exome sequencing data sets, Incidence in France, Minimal incidence and birth prevalence by country, and 9 further topics. 13 evidence topics quoted from 11 sources."
canonical: "https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/product-information-and-disease-description/incidence"
published: "2026-11-19T12:08:36-05:00"
modified: "2026-11-19T12:08:36-05:00"
---

# Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Incidence

<a id="heading-2.2.1.2.1"></a>

## 2.2.1.2.1 Incidence of Niemann-Pick disease type C

<a id="topic-2.2.1.2.1-1"></a>

### Guideline incidence estimate and range across national studies

> “Statement #2: NPC disease is ultra‐rare, with an estimated incidence of one case per 100 000 live births.”
> “The disease is pan‐ethnic, with at least 95% of all cases attributed to variants in NPC1, and the remainder in NPC2.”
> “The milder forms of the disease remain underdiagnosed.”
> “Retrospective, national expert center‐based studies from Australia, the Netherlands, the UK, Portugal, the Czech Republic, France, and the United Arab Emirates have reported an annual incidence varying between 0.25 and 2.20 per 100 000 live births”

Source: [Hiwot et al. (2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13110917/)

<a id="topic-2.2.1.2.1-2"></a>

### Incidence predicted from exome sequencing data sets

> “We determined a combined incidence of classical NPC of 1/89,229 or 1.12 affected patients per 100,000 conceptions, but predict incomplete ascertainment of a lateonset phenotype of NPC1.”
> “Our data suggests an incidence rate for NPC1 and NPC2 of 1/92,104 and 1/2,858,998, respectively.”
> “However, evaluation of common NPC1 variants, suggests that there may be a late-onset NPC1phenotype with a markedly higher incidence on the order of 1/20,000–39,000.”

Source: [Wassif et al. (2016)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4486368/)

<a id="topic-2.2.1.2.1-3"></a>

### Incidence in France

> “The incidence of NPC in France has been calculated at about 1:120,000, based on the number of individuals diagnosed postnatally in a ten-year period versus the number of births during the same period.”
> “When pregnancies that did not result in a live-born infant were included, a slightly higher incidence of 1:100,000 was found”

Source: [Bremova-Ertl and Patterson (2025)](https://www.ncbi.nlm.nih.gov/books/NBK1296/)

<a id="topic-2.2.1.2.1-4"></a>

### Minimal incidence and birth prevalence by country

> “Niemann-Pick C disease (NP-C) is a neurovisceral atypical lysosomal lipid storage disorder with an estimated minimal incidence of 1/120 000 live births.”
> “Estimates of birth prevalence ranging between 0.66 and 0.83 per 100,000 were proposed for France, the UK and Germany based on diagnoses made in the laboratory of the author over the period 1988-2002”

Source: [Vanier (2010)](https://pmc.ncbi.nlm.nih.gov/articles/PMC2902432/)

<a id="topic-2.2.1.2.1-5"></a>

### Birth prevalence by country and in Quebec

> “Elsewhere in the world, the prevalence of NP-C for 100,000 live births is 0.47 in Australia44, 0.91 in Czech Republic15, 2.2 in Northern Portugal4, 0.35 in the Netherlands3, 0.82 for France5, 0.78 for the United Kingdom45 and 1.12 for the United States of America (USA)46.”
> “By combining these different prevalences, we obtain an average of 0.95 cases per 100,000 births.”
> “We estimate a prevalence of 0.61 per 100,000 births in Quebec.”

Source: [Labrecque et al. (2021)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8604933/)

<a id="topic-2.2.1.2.1-6"></a>

### Birth incidence in Australia

> “Niemann–Pick disease type C (NP‐C) is the fifth most prevalent lysosomal disorder in Australia (1 in 112 000 live births).”

Source: [Tchan et al. (2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13193484/)

<a id="topic-2.2.1.2.1-7"></a>

### Estimated new cases per year in the United States

> “Based on the published literature, there are an estimated 42 new NPC cases per year.”

Source: [Burton et al. (2021)](https://pubmed.ncbi.nlm.nih.gov/34304992/)

<a id="topic-2.2.1.2.1-8"></a>

### Distribution of clinical forms in eight national and international cohorts

| Cohort | Acute perinatal form (%) | Early infantile neurological onset (%) | Late infantile neurological onset (%) | Juvenile neurological onset (%) | Adult neurological onset (%) | Total no. |
| --- | --- | --- | --- | --- | --- | --- |
| France and European countries | “12” | “30” | “23” | “30” | “5” | “125” |
| Spain | “7” | “37” | “21” | “25” | “11” | “57” |
| Italy | “7” | “26” | “32” | “23” | “12” | “43” |
| France | “9” | “26” | “22” | “26” | “16” | “107” |
| Germany | “3” | “3” | “35” | “54” | “5” | “37” |
| Czech Republic | “6” | “17” | “24” | “37” | “17” | “54” |
| UK | “5” | “6” | “39” | “32” | “19” | “132” |
| European countries | “—” | “11” | “31” | “31” | “27” | “145” |

Source: [Hiwot et al. (2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13110917/)

<a id="topic-2.2.1.2.1-9"></a>

### Regional variation in the early infantile form

> “Two features emerge from the compiled data presented in Table 1: the early infantile neurological onset form appears more frequent in Southern Europe and the Middle East, and patients with the adult‐onset neurological form seem to represent at least 20% of the cases of NPC and, owing to their longer survival, probably constitute the largest patient group in terms of disease prevalence”

Source: [Hiwot et al. (2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13110917/)

<a id="topic-2.2.1.2.1-10"></a>

### Distribution by age at neurological onset: International Niemann-Pick Disease Registry

> “A total of 203 NPC patients from six European countries were included in this study.”
> “Among enrolled patients, 168 had known neurological manifestations: 43 (24.2%) had early-infantile onset, 47 (26.4%) had late-infantile onset, 41 (23.0%) had juvenile onset, and 37 (20.8%) had adult onset.”
> “10 (5.6%) patients had the neonatal rapidly fatal systemic form.”

Source: [Bolton et al. (2022)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8842861/)

<a id="topic-2.2.1.2.1-11"></a>

### Distribution by age at neurological onset: pooled national cohorts and NPC Registry

> “Data for 789 patients from five large national cohorts and from the NPC Registry were collected and combined.”
> “The Neurological onset group comprised 97 early infantile, 210 late infantile, 198 juvenile, and 163 adolescent/adult patients (Table 1).”

Source: [Patterson et al. (2020a)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7540716/)

<a id="topic-2.2.1.2.1-12"></a>

### Distribution by age at neurological onset: NPC Registry at closure

> “At database closure, 472 patients from 22 countries were enrolled in the NPC Registry (see Additional file 1), with a similar proportion of males (n = 245; 51.9%) and females (n = 227; 48.1%).”
> “Patients with known age at onset of neurological symptoms (n = 422) were categorized as early-infantile (n = 57; 13.5%), late-infantile (n = 108; 25.6%), juvenile, (n = 134; 31.8%), or adolescent/adult (n = 123; 29.1%) onset (Table 2).”

Source: [Patterson et al. (2020b)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7183679/)

<a id="topic-2.2.1.2.1-13"></a>

### Early infantile neurological onset among patients diagnosed in France, 1990 to 2013

> “During the period 1990–2013, a total of 153 new patients with NP-C (from perinatal period to adulthood) were diagnosed in France, among which 32 patients (21%) with neurological onset before 2 years of age, who were thus classified as suffering from the EI neurological form of the disease.”

Source: [Freihuber et al. (2023)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10362619/)

## Related pages
- [Adrabetadex (Lembaz): Infantile-onset Niemann-Pick disease type C](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Terms and abbreviations](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/terms-and-abbreviations.md)
- [Adrabetadex (Lembaz): Infantile-onset Niemann-Pick disease type C](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/executive-summary) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/executive-summary.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Product information and disease description](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/product-information-and-disease-description.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Clinical evidence](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/clinical-evidence.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Economic information and modeling report](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/economics) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/economics.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: References](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/references) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/references.md)
